MedPath

GRVOTS for Tuberculosis patient

Not Applicable
Conditions
Tuberculosis patient treatment adherence.
Tuberculosis of lung, bacteriologically and histologically negativeTuberculous: bronchiectasis, fibrosis of lung, pneumonia, pneumothorax, bacteriologically and histologically negative
A16.0
Registration Number
IRCT20230308057657N1
Lead Sponsor
World Health Organization
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Ability to speak and read English or BM
Working-aged TB patients (19-64 years old)
Newly diagnosed with PTB (first-line treatment)
Has completed the in-person DOT at least two weeks (ensuring medications tolerance)
Willing and able to provide informed consent
Knowledge in smartphone and apps usage

Exclusion Criteria

Patients with drug-resistant TB
Patients with health conditions that disallow them to use a smartphone (severe arthritis, vision impairment)
Patients with no knowledge of smartphone usage

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of video received via the mobile apps (VDOTS). Timepoint: Baseline (before intervention) and 4 and 8 weeks after intervention. Method of measurement: Number of video (VDOTS) received.;Medication Adherence Score. Timepoint: Baseline (before intervention) and 4 and 8 weeks after intervention. Method of measurement: My MAAT (Malaysian Medication Adherence Assessment Tools).;Motivation Score. Timepoint: Baseline (before intervention) and 4 and 8 weeks after intervention. Method of measurement: Intrinsic Motivation Inventory (IMI Tools).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath